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 Chlamydia and Gonorrhea are two sexually transmitted infections (STIs) that are 
extremely common in the United States as well as elsewhere in the world. Chlamydia, 
specifically, is the number one most reported bacterial infection with 2.8 million new cases every 
year.1 This is a conservative estimate considering that most people are asymptomatic and males 
are less likely to get screened. There are over 20 million people diagnosed with an STI each year, 
and the direct healthcare costs add up to over 16 billion dollars annually.1  
 While most women over 18 are screened for STIs during routine Pap smears, many 
women still fall through the cracks. In 2014, the National Center for Health Statistics found that 
only 69.4% of women over 18 in the US had a Pap within the last three years.2  Also, adolescents 
under the age of 21 who are sexually active are at high risk for STIs and are not likely to get 
routine screening. Approximately 42% of adolescents aged 15-19 have been sexually active and 
are not routinely screened.2 
 Chlamydia and gonorrhea are not benign and can have long-lasting negative health 
effects if left untreated. The consequences of untreated STIs in women can be severe and 
permanent. Therefore, it is important to utilize every opportunity for screening that is available. 
Specifically, untreated or recurrent Chlamydia is the number one cause of ectopic pregnancy, 
tubal infertility, and pelvic inflammatory disease (PID).3 Recurrent infections and subsequent 
PID can also lead to chronic abdominal and pelvic pain.4 The average lifetime cost of treatment 
for patients with PID is $6,840.00 per patient.5 Additionally, preventative screening for 
Chlamydia in women under the age of 25 is considered one of the top public health priorities as 
far as economic and health benefits are concerned.6 
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 The opportunity for testing should be better utilized in acute care settings with patients 
that are high-risk and symptomatic. One complaint that is commonly seen in this setting is 
painful urination, also known as dysuria. Urinary tract infections (UTI) and STIs share 
concomitant risk factors including new sexual partners, sexual activity, and lack of contraceptive 
use.7 UTIs in women are a very common ailment seen throughout all levels of care including the 
emergency department (ED), urgent care clinics, and primary care. While many of these women 
have typical UTIs and are diagnosed as such, symptoms of a UTI can also be caused by STIs 
including, but not limited to, Chlamydia and gonorrhea.7 Many women who are diagnosed and 
treated for a UTI may actually have an STI in place of, or in addition to, a UTI. In one study 
9.8% of patients presenting with typical UTI symptoms were positive for Chlamydia, with 
another 7.6% positive for trichomoniasis.8 
 Women with complaints of dysuria, urinary frequency, suprapubic discomfort, urinary 
urgency, and hematuria are typically tested for UTI with a simple urine dipstick or laboratory 
urinalysis with a differential. Frequently the result is inconclusive, but patients are typically 
treated with antibiotics and a urine culture may or may not be ordered depending on their age, 
pregnancy status, and urologic history. For some patients who voice a concern about STIs but are 
asymptomatic, a urine gonorrhea and Chlamydia test may be ordered. The urine that is provided 
for this test is supposed to be a “dirty-catch;” whereas the urine provided for urinalysis should be 
a “clean-catch.” At this particular setting a single urine sample is used for all tests, and it is not 
indicated whether it is clean or dirty catch on the label. Many nurses teach the patients how to 
provide a clean-catch urine, but many do not. And so, it is unknown whether the patients end up 
providing a clean or dirty-catch urine.  
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 These inconsistencies can easily be prevented with the implementation of vaginal self-
swabbing for GC/chlamydia in addition to a clean-catch urine sample to rule out GC/Chlamydia 
in female patients under the age of 25. Places like Planned Parenthood are already using this 
technique for STI testing, and there is strong data showing that self-swabbing is just as accurate 
as pelvic exam swabs taken by a provider.9-11 Additionally, research has shown that patients in 
this age range prefer vaginal self-swabbing to pelvic examination, and do not have any difficulty 
in following directions for self-swabbing.12-14 
 Lastly, active duty military service members historically have higher rates of Chlamydia 
and gonorrhea infections than the general population.15 Currently there are not any kind of 
preventative programs in place to address this besides routine Pap smears, which are enforced for 
all active duty service members, but not necessarily their family members or other dependents. 
There is data that is being monitored through The Healthcare Data and Information Set (HEDIS) 
measures, which include diagnosis of Chlamydia in all age groups. This is a national healthcare 




 The setting for this project is a large military medical treatment facility emergency 
department in an urban setting. This particular ED is divided into two sections: the main ED and 
Fast Track (FT), which functions as an urgent care clinic. Nurse practitioners (NPs) currently 
staff and run the FT, where this project was focused. All patients are active duty military, their 
immediate families, or retired military. Institutional Review Board (IRB) approval was received 
before implementation of this project. Once obtained, the 8 NP staff members were educated on 
the protocol and how to instruct patients on vaginal self-swabbing.  
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 Over the course of one month all female patients between the ages of 14 and 25 who 
presented to the FT with urinary complaints were offered additional testing for Chlamydia and 
Gonorrhea. Urinary complaints included any of the following: dysuria, urinary urgency, urinary 
frequency, malodorous urine, and post-void suprapubic pressure or pain. Patients were then 
offered to supply a sample using one of three methods of their choice: vaginal self-swabbing, 
provider-obtained swab via pelvic exam, or a dirty-catch urine as long as it had been over one 
hour since the clean-catch urine was provided. 
 The Aptima® swab was utilized in both the vaginal self-swabs and pelvic exam swabs. 
The lab utilized a similar polymerase chain reaction (PCR) testing for urine specimens. Results 
for all testing methods take up to three days, wherein the lab informs the Fast Track staff of any 
positive results. The NPs then call the patients and place prescriptions in the pharmacy for them 
to pick up at whatever time they choose, while also providing important patient education over 
the phone. The results from the lab tests are then recorded in the patient’s electronic medical 




Over the course of one month 15 volunteer female patients were tested for gonorrhea and 
Chlamydia. One patient was postive for Chlamydia and treated appropriately with antiobiotics 
after a call back by the NP three days later. No patients tested positive for gonorrhea. Table 1 
illustrates the patients results.  




11 of 15 patients had a diagnosis of urinary tract infection and would not have been tested 
for gonorrhea or Chlamydia using previous protocol. 75% of patients chose to do the vaginal 
self-swab in lieu of a repeat urine sample or pelvic exam. Table 2 shows the percentages of 
patients that chose each of the methods. The single positive Chlamydia patient was initially 











































The goal of this project was achieved in that testing was increased among high-risk 
patients. Due to the limited amount of data, though, it cannot be said whether there was an 
increase in diagnosis rates compared to before. The one patient who did test positive for 
Chlamydia would likely not have been tested using previous protocols since she was positive for 
UTI. This can be seen as a benefit to that one patient. Testing in itself is a benefit to the hospital 
because it helps increase compliance with HEDIS initiatives, whether there are positive results or 
not.  
What was most interesting regarding the results was how many patients opted for vaginal 
self-swabbing. Prior to instituting this project only one of the nurse practitioners was using self-
swabbing for STI testing. None of the other NPs had ever utilitzed it. Many of them were 
skeptical that patients would want to do self-swabbing in lieu of a repeat urine sample. Out of 15 
patients, 10 opted for self-swabbing. This shows that self-swabbing is likely a more patient-







friendly method of testing. Patients did not want to wait to provide another urine sample. Of 
note, the NPs also stated that no patients declined the testing when they were offered it. 
Limitations included confusion among NP staff about criteria for selecting patients, 
therefore there were three known missed opportunities. It is likely that there were other missed 
opportunites, but with only one project leader and a site mentor, it was impossible to be on site 
continuously to monitor Fast Track patient complaints. There was also confusion about having to 
send a separate specimen since prior to the initiation of this project testing was being done on 
clean-catch urine samples. Another limitation was the short timeframe available to gather data 
and the limited number of patients who met criteria that presented during this 30 day period. 
Lastly, due to concerns over data-sharing, it was not possible to gather pre-data from the Fast 
Track for comparison. This data would have included the number of patients presenting with 
urinary complaints and what percentage of them were tested and diagnosed with gonorrhea and 
chlamydia. It also would have included the methods of testing for each patient. The HEDIS data, 
which was readily available, was not specific enough for this project goal.  
Conclusions 
 
This project examined the effectiveness of instituting a protocol of automatic  gonorrhea 
and Chlamydia testing on high-risk female patients that presented to an urgent care setting with 
urinary complaints. The overall purpose was to increase testing and that was achieved, albeit in a 
small way. This project would ideally be carried on by another student to determine effectiveness 
with a larger number of patients. The project is easily sustainable and the NPs in Fast Track state 
they will continue to offer testing to patients in this age group. Ideally, the most sustainable route 
for continuing this protocol would be adding a flag into the electronic ordering system that 
would alert the provider to order STI testing when a UA was being ordered on patients in high-
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risk age groups. The current ordering system is very outdated and would be difficult to change at 
this time, but could be considered in the future as the system is updated.  
Diagnosing and treating even a small number of patients could prevent long term 
complications and save healthcare dollars. Any patient left untreated could go on to develop PID, 
infertility issues, and chronic pain. Not to mention, they would possibly continue the cycle of 
infection to other people. Until Chlamydia and gonorrhea are a thing of the past, this protocol 
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